help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyazaki, K.
Right arrow Articles by Hayashi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyazaki, K.
Right arrow Articles by Hayashi, Y.
(American Journal of Pathology. 2005;167:1051-1059.)
© 2005 American Society for Investigative Pathology

Analysis of in Vivo Role of {alpha}-Fodrin Autoantigen in Primary Sjögren’s Syndrome

Katsushi Miyazaki*{dagger}, Noriaki Takeda{dagger}, Naozumi Ishimaru*, Fumie Omotehara*, Rieko Arakaki* and Yoshio Hayashi*

From the Department of Pathology,* Tokushima University School of Dentistry, Tokushima; and the Department of Otolaryngology,{dagger} The University of Tokushima, School of Medicine, Tokushima, Japan

The {alpha}-fodrin N-terminal portion (AFN) autoantigen mediates in vivo immunoregulation of autoimmune responses in primary Sjögren’s syndrome (SS). We further examined this process and found that cleavage products of AFN were frequently detected in the salivary gland duct cells of SS patients. In in vitro studies using human salivary gland HSY cells, anti-Fas-induced apoptosis resulted in specific cleavage of {alpha}-fodrin into the 120-kd fragment, in association of {alpha}-fodrin with µ-calpain, and activation of caspase 3. Significant proliferative responses against AFN autoantigen were observed in the peripheral blood mononuclear cells (PBMCs) from SS patients with higher pathological score (grade 4) and with short duration from onset (within 5 years). In vivo roles of AFN peptides were investigated using PBMCs from patients with SS, systemic lupus erythematosus, and rheumatoid arthritis. Significant proliferative T-cell responses of PBMCs to AFN peptide were detected in SS but not in systemic lupus erythematosus or rheumatoid arthritis. AFN peptide induced Th1-immune responses and accelerated down-regulation of Fas-mediated T-cell apoptosis in SS. Our data further elucidate the in vivo role of AFN autoantigen on the development of SS and suggest that the AFN autoantigen is a novel participant in peripheral tolerance.





This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
P. Willeke, M. Gaubitz, H. Schotte, H. Becker, E. Mickholz, W. Domschke, and B. Schluter
Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to {alpha}-fodrin antibodies
Rheumatology, March 1, 2007; 46(3): 479 - 483.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.